BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35337807)

  • 1. Replacement per- and polyfluoroalkyl substances (PFAS) are potent modulators of lipogenic and drug metabolizing gene expression signatures in primary human hepatocytes.
    Marques E; Pfohl M; Wei W; Tarantola G; Ford L; Amaeze O; Alesio J; Ryu S; Jia X; Zhu H; Bothun GD; Slitt A
    Toxicol Appl Pharmacol; 2022 May; 442():115991. PubMed ID: 35337807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of serum-dependent impacts on intracellular accumulation and genomic response of per- and polyfluoroalkyl substances in a placental trophoblast model.
    Bangma J; Szilagyi J; Blake BE; Plazas C; Kepper S; Fenton SE; C Fry R
    Environ Toxicol; 2020 Dec; 35(12):1395-1405. PubMed ID: 32790152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of perfluoroalkyl substances (PFAS) and PFAS mixtures on lipid metabolism in differentiated HepaRG cells as a model for human hepatocytes.
    Sadrabadi F; Alarcan J; Sprenger H; Braeuning A; Buhrke T
    Arch Toxicol; 2024 Feb; 98(2):507-524. PubMed ID: 38117326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARα/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances: An integrated approach.
    Yang W; Ling X; He S; Cui H; Yang Z; An H; Wang L; Zou P; Chen Q; Liu J; Ao L; Cao J
    Environ Int; 2023 Aug; 178():108138. PubMed ID: 37572494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Per- and polyfluoroalkyl substances (PFAS) augment adipogenesis and shift the proteome in murine 3T3-L1 adipocytes.
    Modaresi SMS; Wei W; Emily M; DaSilva NA; Slitt AL
    Toxicology; 2022 Jan; 465():153044. PubMed ID: 34800597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfluorooctanesulfonic acid (PFOS) administration shifts the hepatic proteome and augments dietary outcomes related to hepatic steatosis in mice.
    Marques E; Pfohl M; Auclair A; Jamwal R; Barlock BJ; Sammoura FM; Goedken M; Akhlaghi F; Slitt AL
    Toxicol Appl Pharmacol; 2020 Dec; 408():115250. PubMed ID: 32979393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Throughput Transcriptomic Analysis of Human Primary Hepatocyte Spheroids Exposed to Per- and Polyfluoroalkyl Substances as a Platform for Relative Potency Characterization.
    Rowan-Carroll A; Reardon A; Leingartner K; Gagné R; Williams A; Meier MJ; Kuo B; Bourdon-Lacombe J; Moffat I; Carrier R; Nong A; Lorusso L; Ferguson SS; Atlas E; Yauk C
    Toxicol Sci; 2021 May; 181(2):199-214. PubMed ID: 33772556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of maternal high fat diet on mouse pup metabolic endpoints following perinatal PFAS and PFAS mixture exposure.
    Marques ES; Agudelo J; Kaye EM; Modaresi SMS; Pfohl M; Bečanová J; Wei W; Polunas M; Goedken M; Slitt AL
    Toxicology; 2021 Oct; 462():152921. PubMed ID: 34464680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of sub-lethal metabolic perturbations of select legacy and novel perfluorinated alkyl substances (PFAS) in Daphnia magna.
    Labine LM; Oliveira Pereira EA; Kleywegt S; Jobst KJ; Simpson AJ; Simpson MJ
    Environ Res; 2022 Sep; 212(Pt D):113582. PubMed ID: 35661729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on toxicologically relevant gene expression profiles in a liver-on-a-chip model.
    Solan ME; Schackmuth B; Bruce ED; Pradhan S; Sayes CM; Lavado R
    Environ Pollut; 2023 Nov; 337():122610. PubMed ID: 37742859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum per- and polyfluoroalkyl substances and abnormal lipid metabolism: A nationally representative cross-sectional study.
    Wu B; Pan Y; Li Z; Wang J; Ji S; Zhao F; Chang X; Qu Y; Zhu Y; Xie L; Li Y; Zhang Z; Song H; Hu X; Qiu Y; Zheng X; Zhang W; Yang Y; Gu H; Li F; Cai J; Zhu Y; Cao Z; S Ji J; Lv Y; Dai J; Shi X
    Environ Int; 2023 Feb; 172():107779. PubMed ID: 36746113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of bile acid metabolism by perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) in human HepaRG hepatoma cells.
    Behr AC; Kwiatkowski A; Ståhlman M; Schmidt FF; Luckert C; Braeuning A; Buhrke T
    Arch Toxicol; 2020 May; 94(5):1673-1686. PubMed ID: 32253466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction.
    Beggs KM; McGreal SR; McCarthy A; Gunewardena S; Lampe JN; Lau C; Apte U
    Toxicol Appl Pharmacol; 2016 Aug; 304():18-29. PubMed ID: 27153767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to a mixture of legacy, alternative, and replacement per- and polyfluoroalkyl substances (PFAS) results in sex-dependent modulation of cholesterol metabolism and liver injury.
    Roth K; Yang Z; Agarwal M; Liu W; Peng Z; Long Z; Birbeck J; Westrick J; Liu W; Petriello MC
    Environ Int; 2021 Dec; 157():106843. PubMed ID: 34479135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional effects of binary combinations of PFAS in FaO cells.
    Bjork JA; Dawson DA; Krogstad JO; Wallace KB
    Toxicology; 2021 Dec; 464():152997. PubMed ID: 34695511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of human nuclear receptors by perfluoroalkylated substances (PFAS).
    Behr AC; Plinsch C; Braeuning A; Buhrke T
    Toxicol In Vitro; 2020 Feb; 62():104700. PubMed ID: 31676336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An 'Omics Approach to Unraveling the Paradoxical Effect of Diet on Perfluorooctanesulfonic Acid (PFOS) and Perfluorononanoic Acid (PFNA)-Induced Hepatic Steatosis.
    Pfohl M; Marques E; Auclair A; Barlock B; Jamwal R; Goedken M; Akhlaghi F; Slitt AL
    Toxicol Sci; 2021 Apr; 180(2):277-294. PubMed ID: 33483757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct inhibition of human and rat 11β-hydroxysteroid dehydrogenase 2 by per- and polyfluoroalkyl substances: Structure-activity relationship and in silico docking analysis.
    Zhao C; Wang S; Zhai Y; Wang M; Tang Y; Li H; Im YJ; Ge RS
    Toxicology; 2023 Apr; 488():153484. PubMed ID: 36878351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Per- and Polyfluoroalkyl Substances (PFAS) in Breast Milk: Concerning Trends for Current-Use PFAS.
    Zheng G; Schreder E; Dempsey JC; Uding N; Chu V; Andres G; Sathyanarayana S; Salamova A
    Environ Sci Technol; 2021 Jun; 55(11):7510-7520. PubMed ID: 33982557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative toxicokinetics and toxicity of PFOA and its replacement GenX in the early stages of zebrafish.
    Satbhai K; Vogs C; Crago J
    Chemosphere; 2022 Dec; 308(Pt 1):136131. PubMed ID: 36007738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.